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Reference interval determination for serum and urine aldosterone for 
healthy Belgian population  
Background: 
 
Aldosterone measurement is critical for the screening and diagnosis of primary aldosteronism and other 
disorders of the renin-angiotensin system. Liquid chromatography coupled to triple quadrupole mass 
spectrometry (LC-MS/MS) has become an essential tool for small molecule quantitation. We have switched 
from the RIA to LC-MS/MS. Change the method used in the lab means new reference range. So we present a 
reference interval study for both urine and plasma aldosterone for a healthy Belgian population determined by 
LC-MS/MS. 
Materials and Methods:  
 
For the reference interval study, we enrolled 224 healthy Caucasian volunteers (98M:  mean age 35 ± 11 y 
and 126 F: mean age 43 ± 12 y). A subset of 95 healthy volunteers agreed to collect a 24h urine.  
Exclusion criteria were: prescription of any medications (including oral contraceptives), history of 
hypertension, abnormal plasma sodium and body mass index (BMI) >30 kg/m².  
We measured urine sodium concentration on a Cobas c501 (Roche Diagnostic, Manheim, Germany) and 
calculated daily excretion of NaCl using: the following formula: ExcNaCl = 58×V24h ×[Na], where ExcNaCl is the 
24h urine excretion of NaCl in mg/d. 
Aldosterone was measured by LC-MS/MS (TQ5500, ABSciex, Framingham, Massachusetts, USA) (Fig 1) 
The urine samples were centrifuged; an acid hydrolysis of 18 hours was performed, after deuterium labelled 
aldosterone was added as internal standard and injected in LC.  
The plasma samples were centrifuged; deuterium labelled aldosterone was added as internal standard and a 
liquid-liquid extraction (LLE) was performed. The supernatant was evaporated, dissolved in a mix 
water/methanol (50/50) and analyzed by LC-MS/MS.  
 
Quantitative analysis was performed using multiple reaction monitoring (MRM) transition pairs for sample and 
internal standard. In negative ion mode, aldosterone can be quantified using the MRM transition at 359.2>189 
(quantifier ion) and 359.2>331.1 (qualifier ion).  




The distribution was not normal in our reference population for 
urine, the  95th percentile was 24.6 (90%CI: 21.6-27.6) µg/day (24 
hours) (Fig 2).  
Mean sodium intake was 8.9 ± 3.2 g/24 hours and was not 
significantly different (p=0.27) in men and women. 
 Plasma aldosterone concentrations were not normally distributed 
for women but well for men.  
We found a significant difference between levels according to 
gender (p<0.0001); the 95th percentile was 175 (90%CI: 160.2-
189.5) ng/L for women (Fig 3) and 104 (90%CI:92.2-114.5) ng/L for 
men (Fig 4). 
Conclusions:  
 
We have provided reference intervals on a well-characterized population of normotensive healthy young 
subjects free of interfering medications. Finally, we urge the Clinical Chemistry community to develop an 
international standard reference material for aldosterone and a candidate reference method for LC-MS/MS. 
Once this standard is available, new studies for ARR cut-offs will be required in order to better screen the 
patients at risk of PA.  
Figure 2: Box and Whisker plot for urinary aldosterone 
reference values 
 
Figure 3: Box and Whisker plot for  
women plasmatic aldosterone reference values 
Figure 4: Box and Whisker plot for  
men plasmatic aldosterone reference values 
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